Increased SPC24 in prostatic diseases and diagnostic value of SPC24 and its interacting partners in prostate cancer.
Increased SPC24 in prostatic diseases and diagnostic value of SPC24 and its interacting partners in prostate cancer.
复制标题
SPC24 在前列腺疾病中的增加以及 SPC24 及其相互作用伙伴在前列腺癌中的诊断价值
DOI:
10.3892/etm.2021.10355
复制
发表时间:
2021-09
影响因子:
2.7
通讯作者:
Yang X
中科院分区:
文献类型:
--
作者:
Chen S;Wang X;Zheng S;Li H;Qin S;Liu J;Jia W;Shao M;Tan Y;Liang H;Song W;Lu S;Liu C;Yang X
SPC24 is a crucial component of the mitotic checkpoint machinery in tumorigenesis. High levels of SPC24 have been found in various cancers, including breast cancer, lung cancer, liver cancer, osteosarcoma and thyroid cancer. However, to the best of our knowledge, the impact of SPC24 on prostate cancer (PCa) and other prostate diseases remains unclear. In the present study expression of global SPC24 messenger RNA (mRNA) was assessed in a subset of patients with PCa included in The Cancer Genome Atlas (TCGA) database. Increased levels of SPC24 expression were found in PCa patients >60 years old compared to patients <60 and increased SPC24 expression was also associated with higher levels of prostate specific antigen (P<0.05) and lymph node metastasis (P<0.05). Higher levels of SPC24 expression were associated with negative outcomes in PCa patients (P<0.05). Furthermore, in Chinese patients with prostatitis, benign prostatic hypertrophy (BPH) and PCa, SPC24 was expressed at significantly higher levels than that in adjacent/normal tissues, as assessed by reverse transcription-quantitative polymerase chain reaction, immunohistochemistry and western blotting. High expression of SPC24 was associated with high Gleason stages (IV and V; P<0.05). Further analysis, based on Gene Ontology and pathway functional enrichment analysis, suggested that nuclear division cycle 80 (NDC80), an SPC24 protein interaction partner, and mitotic spindle checkpoint serine/threonine-protein kinase BUB1 (BUB1), a core subunit of the spindle assembly checkpoint, may be associated with SPC24 in PCa development. Finally, using binary logistic regression, algorithms combining the receiver operating characteristic between SPC24 and BUB1 or NDC80 indicated that a combination of these markers may provide better PCa diagnosis ability than other PCa diagnosis markers. Taken together, these findings suggest that SPC24 may be a promising prostate disease biomarker.
登录
查看更多内容
DOI:
10.1083/jcb.201012035
发表时间:
2011-06-13
期刊:
The Journal of cell biology
影响因子:
--
作者:
Ricke RM;Jeganathan KB;van Deursen JM
通讯作者:
van Deursen JM
影响因子:
8.8
作者:
Hung SC;Lai SW;Tsai PY;Chen PC;Wu HC;Lin WH;Sung FC
通讯作者:
Sung FC
DOI:
10.1186/s13046-015-0127-8
发表时间:
2015-02-06
期刊:
Journal of experimental & clinical cancer research : CR
影响因子:
--
作者:
Merola R;Tomao L;Antenucci A;Sperduti I;Sentinelli S;Masi S;Mandoj C;Orlandi G;Papalia R;Guaglianone S;Costantini M;Cusumano G;Cigliana G;Ascenzi P;Gallucci M;Conti L
通讯作者:
Conti L
影响因子:
2.1
作者:
Marks, Leonard S.;Fradet, Yves;Groskopf, Jack
通讯作者:
Groskopf, Jack
影响因子:
1.6
作者:
Mao Z;Ji A;Yang K;He W;Hu Y;Zhang Q;Zhang D;Xie L
通讯作者:
Xie L